The Native Antigen Company Limited

POWER SEARCH PRICING

SOLUTIONS

the native antigen company limited Company Information

Live

EstablishedSmallDeclining

Company Number

07386339

Website

thenativeantigencompany.com

Registered Address

lgc queens road, teddington, TW11 0LY

Industry

Research and experimental development on biotechnology

Telephone

01865595230

Next Accounts Due

December 2024

Group Structure

View All

Directors

Euan O'Sullivan3 Years

View All

Shareholders

lgc (holdings) limited 100%

the native antigen company limited Estimated Valuation

£22.4m

Pomanda estimates the enterprise value of THE NATIVE ANTIGEN COMPANY LIMITED at £22.4m based on Net Assets of £10.4m and 2.15x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

The Native Antigen Company Limited is a live company located in teddington, TW11 0LY with a Companies House number of 07386339. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in September 2010, it's largest shareholder is lgc (holdings) limited with a 100% stake. The Native Antigen Company Limited is a established, small sized company, Pomanda has estimated its turnover at £4.4m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded The Native Antigen Company Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

5 Strong

4 Regular

3 Weak

Size

annual sales of £4.4m, make it larger than the average company (£3.3m)

Growth

3 year (CAGR) sales growth of -19%, show it is growing at a slower rate (13.1%)

EXPORT

The Native Antigen Company Limited's latest turnover from March 2023 is estimated at £4.4 million and the company has net assets of £10.4 million. According to their latest financial statements, The Native Antigen Company Limited has 35 employees and maintains cash reserves of £6.9 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Jul 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011
Turnover	4,399,730	3,902,613	3,718,551	8,183,390	2,380,262	2,024,783	1,723,618	1,051,616	1,422,781	792,805	669,109	352,472	353,991
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	2,068,634	1,967,392	1,812,446	3,798,828	1,149,635	918,823	804,368	541,494	694,842	404,356	365,497	182,534	178,231
Gross Profit	2,331,096	1,935,221	1,906,106	4,384,562	1,230,627	1,105,961	919,250	510,122	727,939	388,449	303,612	169,938	175,760
Admin Expenses	1,204,799	286,910	-1,521,681	627,270	778,590	749,197	331,465	277,915	856,475	396,339	320,422	144,040	347,028
Operating Profit	1,126,297	1,648,311	3,427,787	3,757,292	452,037	356,764	587,785	232,207	-128,536	-7,890	-16,810	25,898	-171,268
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	297,957	48,197	4,158	1,705	6,538	5,443	1,314	776	649	783	966	952	494
Pre-Tax Profit	1,424,254	1,696,507	3,431,946	3,758,998	458,575	362,207	589,099	232,983	-127,887	-7,107	-15,844	26,850	-170,774
Tax	-270,608	-322,336	-652,070	-714,210	-87,129	-68,819	-111,929	-46,596	0	0	0	-6,444	0
Profit After Tax	1,153,646	1,374,171	2,779,876	3,044,788	371,446	293,388	477,170	186,386	-127,887	-7,107	-15,844	20,406	-170,774
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	1,153,646	1,374,171	2,779,876	3,044,788	371,446	293,388	477,170	186,386	-127,887	-7,107	-15,844	20,406	-170,774
Employee Costs	2,489,626	2,529,866	2,357,935	2,088,327	1,840,080	1,566,523	984,143	848,201	881,208	477,570	358,795	207,820	256,262
Number Of Employees	35	35	35	31	28	25	18	15	16	9	7	4	5
EBITDA*	1,714,381	1,997,379	3,638,459	3,917,722	650,794	505,141	696,826	288,114	-55,510	48,292	13,656	35,027	-169,666

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Jul 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011
Tangible Assets	2,545,236	1,029,163	606,342	567,447	360,050	330,930	392,431	56,422	77,528	86,894	85,790	32,147	18,348
Intangible Assets	308,980	257,648	173,866	26,776	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	2,854,216	1,286,811	780,208	594,223	360,050	330,930	392,431	56,422	77,528	86,894	85,790	32,147	18,348
Stock & work in progress	1,531,998	1,337,609	1,353,310	876,850	555,497	310,489	186,447	124,328	107,431	81,599	45,944	31,128	9,946
Trade Debtors	834,557	533,324	785,192	2,606,107	356,333	268,717	356,242	161,804	303,718	154,014	130,244	59,724	70,158
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	132,585	368,200	173,281	272,890	227,380	255,331	204,014	80,295	0	0	0	0	0
Cash	6,946,775	7,074,751	5,777,695	2,539,114	871,677	871,745	579,849	471,360	149,087	110,535	202,796	183,408	197,576
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	9,445,915	9,313,884	8,089,478	6,294,961	2,010,887	1,706,282	1,326,552	837,787	560,236	346,148	378,984	274,260	277,680
total assets	12,300,131	10,600,695	8,869,686	6,889,184	2,370,937	2,037,212	1,718,983	894,209	637,764	433,042	464,774	306,407	296,028
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	409,289	668,305	298,462	577,569	158,092	174,684	153,703	77,917	113,269	79,882	87,242	41,574	51,601
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	66,363	0	0	0	0	0	0	0	0	0
other current liabilities	1,431,115	518,042	617,874	1,179,883	245,468	197,858	170,163	122,177	0	0	0	0	0
total current liabilities	1,840,404	1,186,347	916,336	1,823,815	403,560	372,542	323,866	200,094	113,269	79,882	87,242	41,574	51,601
loans	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	51,180	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	3,133	0	90,178	157,469	225,229	1,397	18,163	14,187	31,452	0	0
provisions	55,030	163,297	73,337	67,817	42,425	43,873	0	0	0	0	0	0	0
total long term liabilities	55,030	163,297	76,470	118,997	132,603	201,342	225,229	1,397	18,163	14,187	31,452	0	0
total liabilities	1,895,434	1,349,644	992,806	1,942,812	536,163	573,884	549,095	201,491	131,432	94,069	118,694	41,574	51,601
net assets	10,404,697	9,251,051	7,876,880	4,946,372	1,834,774	1,463,328	1,169,888	692,718	506,332	338,973	346,080	264,833	244,427
total shareholders funds	10,404,697	9,251,051	7,876,880	4,946,372	1,834,774	1,463,328	1,169,888	692,718	506,332	338,973	346,080	264,833	244,427

	Mar 2023	Mar 2022	Mar 2021	Jul 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011
Operating Activities
Operating Profit	1,126,297	1,648,311	3,427,787	3,757,292	452,037	356,764	587,785	232,207	-128,536	-7,890	-16,810	25,898	-171,268
Depreciation	513,416	292,011	208,596	158,944	198,757	148,377	109,041	55,907	73,026	56,182	30,466	9,129	1,602
Amortisation	74,668	57,057	2,076	1,486	0	0	0	0	0	0	0	0	0
Tax	-270,608	-322,336	-652,070	-714,210	-87,129	-68,819	-111,929	-46,596	0	0	0	-6,444	0
Stock	194,389	-15,701	476,460	321,353	245,008	124,042	62,119	16,897	25,832	35,655	14,816	21,182	9,946
Debtors	65,618	-56,949	-1,920,524	2,295,284	59,665	-36,208	318,157	-61,619	149,704	23,770	70,520	-10,434	70,158
Creditors	-259,016	369,843	-279,107	419,477	-16,592	20,981	75,786	-35,352	33,387	-7,360	45,668	-10,027	51,601
Accruals and Deferred Income	913,073	-99,832	-562,009	934,415	47,610	27,695	47,986	122,177	0	0	0	0	0
Deferred Taxes & Provisions	-108,267	89,960	5,520	25,392	-1,448	43,873	0	0	0	0	0	0	0
Cash flow from operations	1,729,556	2,107,664	3,594,857	1,966,159	288,562	441,037	328,393	373,065	-197,659	-18,493	-26,012	7,808	-198,169
Investing Activities
capital expenditure	-2,155,489	-855,671	-396,657	-394,603	-227,877	-86,876	-445,050	-34,801	-63,660	-57,286	-84,109	-22,928	-19,950
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-2,155,489	-855,671	-396,657	-394,603	-227,877	-86,876	-445,050	-34,801	-63,660	-57,286	-84,109	-22,928	-19,950
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	-117,543	117,543	0	0	0	0	0	0	0	0	0
other long term liabilities	0	-3,133	3,133	-90,178	-67,291	-67,760	223,832	-16,766	3,976	-17,265	31,452	0	0
share issue	0	0	150,632	66,810	0	52	0	0	295,246	0	97,091	0	415,201
interest	297,957	48,197	4,158	1,705	6,538	5,443	1,314	776	649	783	966	952	494
cash flow from financing	297,957	45,064	40,380	95,880	-60,753	-62,265	225,146	-15,990	299,871	-16,482	129,509	952	415,695
cash and cash equivalents
cash	-127,976	1,297,056	3,238,581	1,667,437	-68	291,896	108,489	322,273	38,552	-92,261	19,388	-14,168	197,576
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-127,976	1,297,056	3,238,581	1,667,437	-68	291,896	108,489	322,273	38,552	-92,261	19,388	-14,168	197,576

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for the native antigen company limited. Get real-time insights into the native antigen company limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for the native antigen company limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

THE NATIVE ANTIGEN COMPANY LIMITED group structure

The Native Antigen Company Limited has no subsidiary companies.

Ultimate parent company

LGC SCIENCE CORPORATION SARL

#0135775

LGC (HOLDINGS) LIMITED

03141667

2 parents

THE NATIVE ANTIGEN COMPANY LIMITED

07386339

THE NATIVE ANTIGEN COMPANY LIMITED Shareholders

lgc (holdings) limited

100%

The Native Antigen Company Limited currently has 3 directors. The longest serving directors include Mr Euan O'Sullivan (Jul 2020) and Mr Euan O'Sullivan (Jul 2020).

officer	country	age	start	end	role
Mr Euan O'Sullivan	United Kingdom	45 years	Jul 2020	-	Director
Mr Euan O'Sullivan	United Kingdom	45 years	Jul 2020	-	Director
Mr Adrian Stevens	United Kingdom	55 years	Nov 2021	-	Director

P&L

March 2023

turnover

4.4m

+13%

operating profit

1.1m

gross margin

53%

+6.85%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

10.4m

+0.12%

total assets

12.3m

+0.16%

cash

6.9m

-0.02%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

bergenbio limited

orchard therapeutics (europe) limited

affinity laboratories limited

therapeutic frontiers limited

biocleave limited

company number

07386339

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

September 2010

age

accounts

Total Exemption Full

ultimate parent company

LGC SCIENCE CORPORATION SARL

previous names

friars 2021 limited (November 2010)

incorporated

address

lgc queens road, teddington, TW11 0LY

last accounts submitted

March 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to the native antigen company limited.

the native antigen company limited Company Information

the native antigen company limited Estimated Valuation

the native antigen company limited Estimated Valuation

the native antigen company limited Estimated Valuation

The Native Antigen Company Limited Overview

The Native Antigen Company Limited Health Check

THE NATIVE ANTIGEN COMPANY LIMITED financials

the native antigen company limited Credit Report and Business Information

The Native Antigen Company Limited Competitor Analysis

the native antigen company limited Ownership

the native antigen company limited directors

the native antigen company limited company details

the native antigen company limited Charges & Mortgages

the native antigen company limited Companies House Filings - See Documents